---
layout: post
title: "Advancing the Development of Interchangeable Products: Identifying Future Needs; Public Workshop; Request for Comments"
date: 2026-02-04 21:49:04 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-15572
original_published: 2025-08-15 00:00:00 +0000
significance: 8.00
---

# Advancing the Development of Interchangeable Products: Identifying Future Needs; Public Workshop; Request for Comments

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** August 15, 2025 00:00 UTC
**Document Number:** 2025-15572

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Advancing the Development of Interchangeable Products: Identifying Future Needs." The purpose of the public workshop is to address a commitment FDA made in the Biosimilar User Fee Act (BsUFA) reauthorization commitment letter for fiscal years (FYs) 2023 through 2027 (BsUFA III) to hold a scientific workshop to discuss and identify future needs (e.g., guidance, research) that, when addressed, may help further advance the development of interchangeable biosimilar products.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/08/15/2025-15572/advancing-the-development-of-interchangeable-products-identifying-future-needs-public-workshop)
- API: https://www.federalregister.gov/api/v1/documents/2025-15572

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
